Literature DB >> 25003054

Second reported case of multilocular hydatid disease in Iraq.

Abdul-Khalik Zaki Benyan1, Nadham Kadham Mahdi2, Fouzi Abdul-Amir1, Osama Ubaid1.   

Abstract

Hydatid disease is an important zoonotic disease with a worldwide distribution. In the Middle East, as well as in some other parts of the world, it has always been a serious economic and public health problem. The disease is endemic and enzootic in Iraq. In Iraq, the disease is caused by Echinococcus granulosus but a multilocular hydatid cyst of E. multilocularis has been recovered from the liver of a woman in Erbil, North Iraq. This paper documents the second case of hydatid disease caused by E. multilocularis, this time reported in Basrah, Southern Iraq.

Entities:  

Year:  2013        PMID: 25003054      PMCID: PMC3991051          DOI: 10.5339/qmj.2013.5

Source DB:  PubMed          Journal:  Qatar Med J        ISSN: 0253-8253


Case report

A 55-year-old Iraqi woman, married with four children living in the rural area of Al-Hartha near Basrah, southern Iraq, was in contact with sheep and dogs. Rodents are also present in the area. She was admitted to Al-Sadar Teaching Hospital complaining of epigastric and right hypochondrial pain and heaviness. Chest X-ray and CT for chest and abdomen showed one cyst in the left lung and another one in the right subdiaphragmatic liver. Surgery was performed, and the two cysts were resected completely and sent for pathological and parasitological examinations. They consisted of many small vesicles embedded in a dense connective tissue stroma. They proved to be multilocular hydatid cysts (Figure 1).
Figure 1.

A cystic lesion revealed by computed tomography of the left lung. It consists of many small vesicles situated in a dense connective tissue stroma.

Discussion

While Echinococcus granulosus is rare, it is also the most virulent species. The life cycle involves two hosts, one definitive and the other intermediate. Humans act as an incidental intermediate host. The disease has been reported in Alaska, Canada, Russia, Siberia, China, Japan as well as Central Europe into Germany and in India. In Iraq multilocular hydatid disease has been reported once in addition to the present case. The clinical presentation of hydatid disease depends on the size and site of the cyst. Some patients are asymptomatic while others may develop dysfunction of involved organs. The hepatic hydatid cyst can induce a structive jaundice and abdominal pain. Pulmonary hydatid cysts produce chronic cough, dyspnea, pleuritic chest pain and hemoptysis. Anaphylactic inflammatory complications may result from free rupture of the cysts as well. Pre-operative clinical diagnosis of hydatid cyst was made ultrasonically and confirmed by a CT scan. These are the best tests to differentiate hydatid cyst from amoebic or pyogenic cysts.
  2 in total

1.  Hydatidosis among Iraqi children.

Authors:  N K Mahdi; A K Benyan
Journal:  Ann Trop Med Parasitol       Date:  1990-06

2.  Simultaneous operation for hydatid cyst of right lung and liver.

Authors:  A Kir; E Baran
Journal:  Thorac Cardiovasc Surg       Date:  1995-02       Impact factor: 1.827

  2 in total
  3 in total

1.  Investigation of Echinococcus multilocularis in Environmental Definitive Host Feces in the Asian and the European Parts of Turkey.

Authors:  Ali Tümay Gürler; Francesca Gori; Cenk Soner Bölükbas; Şinasi Umur; Mustafa Açıcı; Peter Deplazes
Journal:  Front Vet Sci       Date:  2018-03-15

2.  Lasiopodomys fuscus as an important intermediate host for Echinococcus multilocularis: isolation and phylogenetic identification of the parasite.

Authors:  Qi-Gang Cai; Xiu-Min Han; Yong-Hai Yang; Xue-Yong Zhang; Li-Qing Ma; Panagiotis Karanis; Yong-Hao Hu
Journal:  Infect Dis Poverty       Date:  2018-03-31       Impact factor: 4.520

3.  Worldwide literature on epidemiology of human alveolar echinococcosis: a systematic review of research published in the twenty-first century.

Authors:  Sven Baumann; Rong Shi; Wenya Liu; Haihua Bao; Julian Schmidberger; Wolfgang Kratzer; Weixia Li
Journal:  Infection       Date:  2019-05-30       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.